docetaxel anhydrous has been researched along with cystine in 1 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (cystine) | Trials (cystine) | Recent Studies (post-2010) (cystine) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 6,431 | 97 | 1,084 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aa, JY; Cao, B; Guo, SH; Li, SJ; Lu, ZY; Sun, RB; Wang, GJ; Xie, Y | 1 |
1 other study(ies) available for docetaxel anhydrous and cystine
| Article | Year |
|---|---|
Cystine supplementation rebalances the redox homeostasis of microenvironment in non-small cell lung cancer cells and reverses their resistance to docetaxel.
Topics: A549 Cells; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Non-Small-Cell Lung; Cystine; Docetaxel; Drug Resistance, Neoplasm; Drug Synergism; Glutathione; Homeostasis; Humans; Lung Neoplasms; Male; Mice, Nude; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species; Tumor Microenvironment; Up-Regulation | 2021 |